Veliparib With Carboplatin and Paclitaxel and as Continuation Maintenance Therapy in Adults With Newly Diagnosed Stage III or IV, High-grade Serous, Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
- Status
- TERMINATED
- Phase
- PHASE3
Clinical Trials Related to Ovarian Cancer
Related studies linked through entity extraction aliases.
Evaluation of GTPase Inhibition by Post-operative Intravenous Ketorolac in Ovarian Cancer Patients
- Status
- COMPLETED
- Phase
- NA
Carboplatin Plus Docetaxel With Day 2 Pegylated G-CSF (Neulasta®) in Patients With Advanced Stage Ovarian Carcinoma
- Status
- TERMINATED
- Phase
- PHASE2
Pillars4Life Trial
- Status
- COMPLETED
- Phase
- NA
Developing a Stepped Approach to Improving Sexual Function aFteR Treatment fOr gyNaecological Cancer
- Status
- UNKNOWN
- Phase
- NA
T Cell Receptor-transduced T Cells Targeting NY-ESO-1 for Treatment of Patients With NY-ESO-1- Expressing Malignancies
- Status
- UNKNOWN
- Phase
- PHASE1
A Combination Clinical Study of PLX3397 and Pembrolizumab To Treat Advanced Melanoma and Other Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Dose Dense Paclitaxel With Pembrolizumab (MK-3475) in Platinum Resistant Ovarian Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Study of COTI-2 as Monotherapy or Combination Therapy for the Treatment of Malignancies
- Status
- UNKNOWN
- Phase
- PHASE1
A Study of BBI503 in Asymptomatic Recurrent Ovarian Cancer Patients With CA-125 Elevation
- Status
- TERMINATED
- Phase
- PHASE2
Intensive Locoregional Chemoimmunotherapy for Recurrent Ovarian Cancer Plus Intranodal DC Vaccines
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Phase 1/2 Study of Motolimod, Doxorubicin, and Durvalumab in Recurrent, Platinum-Resistant Ovarian Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
TC or BEP in Treating Patients With Ovarian Malignant Sex Cord-Stromal Tumors
- Status
- RECRUITING
- Phase
- PHASE3
TC or BEP in Treating Patients With Malignant Ovarian Germ Cell Tumors
- Status
- RECRUITING
- Phase
- PHASE3
Clinical Trial of Lurbinectedin (PM01183) in Platinum Resistant Ovarian Cancer Patients
- Status
- COMPLETED
- Phase
- PHASE3
Phase I of Carboplatin-Olaparib Followed by Olaparib Monotherapy in Advanced Cancer
- Status
- COMPLETED
- Phase
- PHASE1
AZD9150, a STAT3 Antisense Oligonucleotide, in People With Malignant Ascites
- Status
- TERMINATED
- Phase
- PHASE2
Fermented Wheat Germ Extract in Women With Ovarian Cancer
- Status
- TERMINATED
- Phase
- EARLY_PHASE1
Phase I Trial of VS-6766 Alone and in Combination With Everolimus
- Status
- COMPLETED
- Phase
- PHASE1
Tocotrienol as a Nutritional Supplement in Patients With Advanced Ovarian Cancer
- Status
- COMPLETED
- Phase
- PHASE2